Is TB-500 just another name for thymosin beta-4?
TB-500 is a synthetic fragment related to thymosin beta-4, not the full native protein. Papers about Tβ4 do not automatically describe every compounded TB-500 product.
EDUCATION CENTER
TB-500 Guide
A patient-friendly education resource for clinician-guided TB-500 peptide therapy.
What is TB-500?
TB-500 is a synthetic peptide fragment related to thymosin beta-4 (Tβ4), a naturally occurring actin-binding protein studied for cell migration and wound biology. It is not two names for BPC-157.
TB-500 is not FDA-approved for musculoskeletal injury or athletic recovery. At Vita Bella it is discussed only after licensed provider review of goals, history, and compounding availability.
How it may work
Thymosin beta-4 sequesters G-actin and has been studied in wound-healing and cell-migration models. TB-500 is marketed as a related synthetic fragment; most of the published biology is about Tβ4 itself, not every compounded TB-500 vial.
Human evidence for TB-500 as a recovery drug remains limited compared with physical therapy, load management, and FDA-approved treatments. Your provider will set expectations accordingly.
TB-500 vs BPC-157
BPC-157 is a 15–amino-acid gastric pentadecapeptide. TB-500 is related to thymosin beta-4. They are different sequences, different research histories, and not interchangeable milligram-for-milligram.
Some recovery protocols discuss both. Stacking is a clinician decision. For a side-by-side on the BPC-157 page, see BPC-157 vs TB-500 in the BPC-157 info article.
Potential uses
Clinicians and patients commonly discuss TB-500 in soft-tissue recovery, flexibility, or post-training repair contexts — always inside an individualized plan.
It is not a license to train through a complete tear, infection, or uninvestigated swelling.
Candidate assessment
Candidates are typically adults with clear recovery goals who have been evaluated for contraindications and realistic timelines.
Active infection, uncontrolled systemic disease, pregnancy, or malignancy concerns may make peptide therapy inappropriate until resolved.
Medical evaluation
Share injury history, surgeries, current training load, and other peptides or NSAIDs. Your clinician decides whether TB-500, BPC-157, pentadeca arginate, rehab alone, or a combination is the next step.
Athletes subject to drug testing should know that WADA lists thymosin-β4 and its derivatives (including TB-500) on the Prohibited List.
Forms & dosing
TB-500 is typically discussed as a subcutaneous injectable with individualized reconstitution and schedule.
Internet loading-dose charts are not your prescription. Follow the pharmacy label.
Administration guidance
Use sterile technique, rotate sites, and review Vita Bella injection resources.
Store reconstituted peptide as directed. Discard according to pharmacy dating guidance.
Side effects
Possible effects include injection-site redness, headache, or fatigue. Systematic safety data in healthy athletes are limited.
Report infection at the injection site, unusual swelling, or systemic allergic symptoms promptly.
Safety & quality
Research-chemical TB-500 sold for “not human consumption” skips screening, sterility controls, and follow-up.
Quality compounding, a clear rehab plan, and knowing anti-doping status matter more than stacking every recovery peptide at once.
FAQs
Should I use TB-500, BPC-157, or both?
That is a clinical decision. They are different peptides. Your Vita Bella provider may use one, both, pentadeca arginate, or neither if rehab and load management come first.
Is TB-500 allowed in tested sport?
WADA lists thymosin-β4 and derivatives such as TB-500 as prohibited. If you compete, talk with your sport’s medical staff before any peptide protocol.
References
Related guides
Ready to talk with a Vita Bella provider?
Start with a Vita Bella membership consultation so a licensed provider can review injury history and whether TB-500, BPC-157, pentadeca arginate, or rehab-first care is right for you.